These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7671182)

  • 21. Accelerated atherosclerosis.
    Samra SS; Walwaikar PP; Morye VK; Gawde AG
    J Indian Med Assoc; 2002 Aug; 100(8):516, 518-21. PubMed ID: 12675186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?
    Radovancevic B; Golino A; Vrtovec B; Thomas CD; Radovancevic R; Odegaard P; van Rossem CC; Gaemers SJ; Vaughn WK; Smart FW; Frazier OH
    J Heart Lung Transplant; 2005 Jun; 24(6):703-7. PubMed ID: 15949730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium antagonists suppress atherogenesis in aorta but not in the intramural coronary arteries of cholesterol-fed rabbits.
    Ginsburg R; Davis K; Bristow MR; McKennett K; Kodsi SR; Billingham ME; Schroeder JS
    Lab Invest; 1983 Aug; 49(2):154-8. PubMed ID: 6876744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid disorder and transplant coronary artery disease in long-term survivors of heart transplantation.
    Park JW; Merz M; Braun P; Vermeltfoort M
    J Heart Lung Transplant; 1996 Jun; 15(6):572-9. PubMed ID: 8803754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary artery disease in heart transplant recipients - diagnosis and treatment. Single centre experience based on results of elective coronary angiography.
    Zakliczyński M; Lekston A; Swierad M; Wnek A; Buszman P; Przybylski R; Wojarski J; Przybylski J; Foremny J; Poloński L; Zembala M
    Kardiol Pol; 2003 Feb; 58(2):109-20. PubMed ID: 14504636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atherosclerosis in transplant heart.
    Sharada B; Wasir HS
    J Assoc Physicians India; 1996 Apr; 44(4):269-72. PubMed ID: 9251401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherosclerosis in transplant heart.
    Sharda B; Wasir HS
    J Assoc Physicians India; 1996 Feb; 44(2):131-4. PubMed ID: 10999067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amlodipine reduces graft coronary artery disease in rat heterotopic cardiac allografts.
    Atkinson JB; Wudel JH; Hoff SJ; Stewart JR; Frist WH
    J Heart Lung Transplant; 1993; 12(6 Pt 1):1036-43. PubMed ID: 8312305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of calcium antagonists on atherosclerosis progression and intima media thickness].
    Zannad F
    Drugs; 2000; 59 Spec No 2():39-46. PubMed ID: 11002857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accelerated arteriosclerosis after transplantation: the possible role of calcium channel blockers.
    Atkinson JB
    Int J Cardiol; 1997 Dec; 62 Suppl 2():S125-34. PubMed ID: 9488204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diltiazem prevents accelerated graft coronary artery disease in heart transplant recipients.
    Gheissari A; Yokoyama T; Hendel J; Capouya E; Fuentes J; Jimenez P
    Transplant Proc; 1995 Oct; 27(5):2625-7. PubMed ID: 7482857
    [No Abstract]   [Full Text] [Related]  

  • 33. [Posttransplant complications in cardiac transplant recipients at National Cardiovascular Center].
    Kato T; Nakatani T; Kitamura S
    Kyobu Geka; 2007 Oct; 60(11):963-8. PubMed ID: 17926898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Modification of coronary arteriosclerosis in man by calcium antagonists?].
    Schneider W; Roebruck P; Cieslinski G; Noack H; Kober G; Alle M; Kaltenbach M
    Z Kardiol; 1991; 80 Suppl 9():63-71. PubMed ID: 1796651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Coronary endothelial dysfunction and graft atheromatosis following heart transplantation].
    Vassalli G
    Schweiz Med Wochenschr; 1995 Oct; 125(41):1923-30. PubMed ID: 7481650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of calcium antagonists and atherosclerosis.
    Keogh AM; Schroeder JS
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S28-35. PubMed ID: 1707112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium channel blockers and the prevention of atherosclerosis.
    Gotto AM
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):342S-346S. PubMed ID: 2078321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Use of Calcium Channel Blockers in the Treatment of Coronary Spasm and Atrioventricular Block.
    Gao B; Zhang Z; Qian J; Cao C; Hua X; Chu M; He X; Zeng H
    Cell Biochem Biophys; 2015 Jun; 72(2):527-31. PubMed ID: 25572060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation.
    Rickenbacher PR; Pinto FJ; Lewis NP; Hunt SA; Alderman EL; Schroeder JS; Stinson EB; Brown BW; Valantine HA
    Circulation; 1995 Dec; 92(12):3445-52. PubMed ID: 8521566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient.
    Gao SZ; Schroeder JS; Alderman EL; Hunt SA; Silverman JF; Wiederhold V; Stinson EB
    Circulation; 1987 Nov; 76(5 Pt 2):V56-61. PubMed ID: 3311457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.